. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: Acta Neurol Scand. 2015 Sep 23;134(1):83–86. doi: 10.1111/ane.12505

Table 1. Subject Characteristics.

	PD (N=40)
Gender	Male 31 (77.5%); Female 9
Age	68.70 ± 7.46
Year since diagnosis of PD	9.41 ± 5.72
HY Stage(‘ON meds’)	HY 1.5 (N = 2) HY 2 (N = 10) HY 2.5 (N = 16) HY 3 (N = 12)
UPDRS ‘OFF meds’	30.50 ± 12.35
UPDRS ‘ON meds’	20.13 ± 7.57
Daily Levodopa equivalent dose (mg) (15, 16)	801.55 ± 484.58